SMARCB1 and neoplasm: This gene, recently found altered in AT/RT and elected as a novel therapeutic target for these tumor types21, showed similar chromatin changes upon SWINGN knockdown, corroborating the hypothesis of a regulation orchestrated by SMARCB1 and SWINGN (Fig. 5i).